Extraterrestrial and terrestrial outdoor applications of Mössbauer spectroscopy

„Extraterrestrische und terrestrische Anwendungen eines miniaturisierten Mössbauer-Spektrometers“ Die vorliegende Arbeit befasst sich mit Anwendungen eines miniaturisierten Mössbauer- Spektrometers (MIMOS II), dessen Entwicklung in den frühen neunziger Jahren am Institut für Kernphysik der Technischen Universität Darmstadt unter Professor Egbert Kankeleit und seinen Mitarbeitern begann. Seit 1998 sind die Entwicklungsarbeiten im Arbeitskreis von Prof. Gütlich am Institut für Anorganische und Analytische Chemie der Johannes Gutenberg- Universität Mainz von Dr. Göstar Klingelhöfer und Mitarbeitern fortgesetzt worden. Vorrangiges Ziel war dabei der geplante Einsatz des Spektrometers zu mineralogischen Untersuchungen im Weltall. Entsprechend ist das Projekt mit erheblichen finanziellen Mitteln des Forschungsinstituts der Deutschen Luft- und Raumfahrt (DLR) in Bonn unterstützt worden. Bei den beiden Missionen, die im Jahre 2003 von der NASA zum Mars gesandt wurden und im Januar dieses Jahres die beiden „Mars Exploration Rover“ (MER) "Spirit" und "Opportunity" erfolgreich auf der Marsoberfläche abgesetzt haben, ist jeweils ein MIMOS II-Gerät zur Charakterisierung eisenhaltiger Minerale und Böden während der laufenden Mission im Einsatz. Einige Ergebnisse von MIMOS II an Gestein und Böden der Marsoberfläche werden in der vorliegenden Arbeit präsentiert und diskutiert. Diese Ergebnisse wurden vom MIMOS II-Consortium unter Führung von Dr. Göstar Klingelhöfer, mit Unterstützung des Ingenieurs- und Wissenschaftsteams von MER am Jet Propulsion Laboratory in Kalifornien, erlangt. Erste Spektren, die von Proben im Gusev-Krater (Landestelle von „Spirit“) aufgenommen wurden und in dieser Arbeit vorgestellt werden, weisen auf das Vorkommen von forsteritischem Olivin, Pyroxen, Magnetit hin; daneben zeigt sich ein von Eisen(III) herrührendes Quadrupoldublett, das (noch) nicht eindeutig zugeordnet werden konnte. Aus den gewonnenen Daten wurde geschlossen, dass physikalische Verwitterung der vorherrschende Veränderungsprozess in den Ebenen des Gusev-Kraters ist. Um die Fähigkeiten von MIMOS II in der Charakteriserung extraterrestrischen Materials vor dem Start zum Mars zu demonstrieren, wurde eine Auswahl von chondritischen, Eisenund Marsmeteoriten gemessen. Ein Datenanalysepaket, basierend auf künstlichen neuronalen Netzwerken, genetischen Algorithmen und "fuzzy" Logik, wurde erstellt, erfolgreich getestet und während der Echtzeit-Operation der MER benutzt. Eine Datenbasis von Mössbauer-Parametern und Referenzen von veröffentlichten Studien über den Temperaturbereich des Mars wurde zusammengestellt. Die Werkzeuge zur Datenanalyse eröffnen neue Einsatzmöglichkeiten des miniaturisierten Mössbauer-Spektrometers in vielen Bereichen ausserhalb des Physikllabors. Einige davon werden in dieser Arbeit vorgestellt, wie z.B.die Pigmentcharakterisierung, die Echtheit archäologischer Artefakte oder in-situ Luftverschmutzungsmessungen. Datum: 20.07.2004 1. Betreuer: Professor Dr. P. Gütlich Paulo A. de Souza Jr. GAFEP/GETEP Departamento de Pelotização - DIPE Companhia Vale do Rio Doce - CVRD Tel.: (27) 3333-4609 - Carrier (835)

Simultaneous bilateral hip replacement reveals superior outcome and fewer complications than two-stage procedures: a prospective study including 1819 patients and 5801 follow-ups from a total joint replacement registry

Background Total joint replacements represent a considerable part of day-to-day orthopaedic routine and a substantial proportion of patients undergoing unilateral total hip arthroplasty require a contralateral treatment after the first operation. This report compares complications and functional outcome of simultaneous versus early and delayed two-stage bilateral THA over a five-year follow-up period. Methods The study is a post hoc analysis of prospectively collected data in the framework of the European IDES hip registry. The database query resulted in 1819 patients with 5801 follow-ups treated with bilateral THA between 1965 and 2002. According to the timing of the two operations the sample was divided into three groups: I) 247 patients with simultaneous bilateral THA, II) 737 patients with two-stage bilateral THA within six months, III) 835 patients with two-stage bilateral THA between six months and five years. Results Whereas postoperative hip pain and flexion did not differ between the groups, the best walking capacity was observed in group I and the worst in group III. The rate of intraoperative complications in the first group was comparable to that of the second. The frequency of postoperative local and systemic complication in group I was the lowest of the three groups. The highest rate of complications was observed in group III. Conclusions From the point of view of possible intra- and postoperative complications, one-stage bilateral THA is equally safe or safer than two-stage interventions. Additionally, from an outcome perspective the one-stage procedure can be considered to be advantageous.

Gender, age and ethnic aspects of analgesia in acute abdominal pain: is analgesia even across the groups?

Numerous studies have shown differences in pain perception between men and women, which may affect pain management strategies.

Collapse of telomere homeostasis in hematopoietic cells caused by heterozygous mutations in telomerase genes

Telomerase activity is readily detectable in extracts from human hematopoietic stem and progenitor cells, but appears unable to maintain telomere length with proliferation in vitro and with age in vivo. We performed a detailed study of the telomere length by flow FISH analysis in leukocytes from 835 healthy individuals and 60 individuals with reduced telomerase activity. Healthy individuals showed a broad range in average telomere length in granulocytes and lymphocytes at any given age. The average telomere length declined with age at a rate that differed between age-specific breakpoints and between cell types. Gender differences between leukocyte telomere lengths were observed for all cell subsets studied; interestingly, this trend could already be detected at birth. Heterozygous carriers for mutations in either the telomerase reverse transcriptase (hTERT) or the telomerase RNA template (hTERC) gene displayed striking and comparable telomere length deficits. Further, non-carrier relatives of such heterozygous individuals had somewhat shorter leukocyte telomere lengths than expected; this difference was most profound for granulocytes. Failure to maintain telomere homeostasis as a result of partial telomerase deficiency is thought to trigger cell senescence or cell death, eventually causing tissue failure syndromes. Our data are consistent with these statements and suggest that the likelihood of similar processes occurring in normal individuals increases with age. Our work highlights the essential role of telomerase in the hematopoietic system and supports the notion that telomerase levels in hematopoietic cells, while limiting and unable to prevent overall telomere shortening, are nevertheless crucial to maintain telomere homeostasis with age.

Sequence analysis of the porcine IFNAR1 and IFNGR2 genes

A porcine BAC clone harboring the tightly linked IFNAR1 and IFNGR2 genes was identified by comparative analysis of the publicly available porcine BAC end sequences. The complete 168,835 bp insert sequence of this clone was determined. Sequence comparisons of the genomic sequence with EST sequences from public databases were performed and allowed a detailed annotation of the IFNAR1 and IFNGR2 genes. The analyzed genes showed a conserved genomic organization with their known mammalian orthologs, however the sequence conservation of these genes across species was relatively low. In addition to the IFNAR1 and IFNGR2 genes, which were completely sequenced, the analyzed BAC clone also contained parts of an orphan gene encoding a putative transmembrane protein (TMEM50B). In contrast to the IFNAR1 and IFNGR2 genes the sequence conservation of the TMEM50B gene across different mammalian species was extremely high.

Preventive effects of octreotide (SMS 201-995) on diabetic ketogenesis during insulin withdrawal

1. Exogenous somatostatin inhibits glucagon secretion and prevents ketoacidosis in diabetic patients, but has the therapeutic disadvantage of requiring continuous intravenous infusion to exhibit these effects. 2. Consequently, we examined the effect of subcutaneous administration of the long-acting somatostatin analogue octreotide (SMS 201-995) on early ketogenesis in diabetic ketoacidosis. On two separate occasions insulin was withdrawn over a period of 9 h from seven type I diabetic patients. On the second occasion the patients were given 50 micrograms octreotide s.c. before the insulin withdrawal and every 3 h during insulin withdrawal. 3. Differences in integrated free fatty acid responses (4706 +/- 1227 mumol l-1 h vs 3026 +/- 835 mumol l-1 h, AUC, P = NS) were not significant, but the peak increments of acetoacetate (1413 +/- 354 mumol l-1 vs 612 +/- 176 mumol l-1, P less than 0.05), beta-hydroxybutyrate (2180 +/- 475 mumol l-1 vs 922 +/- 246 mumol l-1, P less than 0.01) and the decrements in plasma bicarbonate (-8 +/- 1 mumol l-1 vs -4 +/- 1 mumol l-1, P less than 0.05) and pH (-0.07 +/- 0.01 vs -0.03 +/- 0.01, P less than 0.05) were significantly less with octreotide. 4. At the same time peak increments of glucagon were lower with octreotide treatment (329 +/- 206 pg ml-1 vs 39 +/- 30 pg ml-1, P less than 0.05). 5. We conclude that, despite accelerated lipolysis and provision of substrate for ketogenesis during insulin withdrawal, this somatostatin analogue significantly reduces ketogenesis resulting from insulin deprivation, probably secondary to decreasing glucagon secretion. This drug may be useful in short term prophylactic treatment of diabetic patients during periods of increased risk for ketoacidosis.

Does diagnostic delay result in decreased survival in paediatric brain tumours?

To study the hypothesis that a delay in the diagnosis of paediatric brain tumours results in decreased survival outcome probability, we compared the prediagnostic period of 315 brain tumour patients (median age 6.7 years, range, 0 to 16 years) with progression-free and overall survival. The median prediagnostic symptomatic interval was 60 days (range, 0 to 3,480 days), with a median parental delay of 14 days (range, 0 to 1,835 days) and a median doctor's delay of 14 days (range, 0 to 3,480 days). The prediagnostic symptomatic interval correlated significantly with the patient age, tumour histology, tumour location and year of diagnosis, but not with gender. We then grouped the patients according to histology (low-grade glioma [n=77], medulloblastoma [n=57], high-grade glioma [n=40], craniopharyngioma [n=27], ependymoma [n=20] and germ cell tumours [n=18]). Contrary to common belief, long prediagnostic symptomatic interval or long doctor's delay did not result in decreased survival outcome probability in any of these groups. The effect of tumour biology on survival seems to be dominant and overwhelms any possible opposing effect on survival of a delay in diagnosis.

Technical advances improved outcome in patients undergoing surgery of the ascending aorta and/or aortic arch: ten years experience

BACKGROUND: Several technical advances in thoracic aortic surgery, such as the use of antegrade cerebral perfusion, avoidance of cross-clamping and the application of glue, have beneficially influenced postoperative outcome. The aim of the present study was to analyse the impact of these developments on outcome of patients undergoing surgery of the thoracic aorta. METHODS AND RESULTS: Between January 1996 and December 2005, 835 patients (37.6%) out of 2215 aortic patients underwent surgery on the thoracic ascending aorta or the aortic arch at our institution. All in-hospital data were assessed. Two hundred and forty-one patients (28.8%) suffered from acute type A dissection (AADA). Overall aortic caseload increased from 41 patients in 1996 to 141 in 2005 (+339%). The increase was more pronounced for thoracic aortic aneurysms (TAA) (+367.9%), than for acute type A aortic dissections (+276.9%). Especially in TAA, combined procedures increased and the amount of patients with impaired left ventricular function (EF <50%) raised up from 14% in 1996 to 24% in 2005. Average age remained stable. Logistic regression curve revealed a significant decrease in mortality (AADA) and in the overall incidence of neurological deficits. CONCLUSIONS: Technical advances in the field of thoracic aortic surgery lead to a decrease of mortality and morbidity, especially in the incidence of adverse neurological events, in a large collective of patients. Long-term outcome and quality of life are better, since antegrade cerebral perfusion has been introduced.